Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Brooklyn. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Brooklyn at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
The purpose of this study is to evaluate the overall survival (length of time from the start of study to date of death from any cause) for pasritamig (JNJ-78278343) in combination with best supportive care (BSC) as compared to placebo with BSC in participants with metastatic castration-resistant prostate cancer (mCRPC; a stage of cancer that has spread beyond the prostate gland and is no longer responding to hormone therapies).
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this prostate cancer clinical trial in Brooklyn, NY
If you're searching for prostate cancer treatment options in Brooklyn, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Brooklyn research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.